“Considering that Gauteng is dealing with the country’s highest number of coronavirus cases, it is imperative that our public health resources can remain focused on treating and containing the coronavirus. By providing this medicine to Charlotte Maxeke Hospital, we are hoping to help the hospital treat at least 700 older patients who would otherwise have to visit the hospital several times to help manage their condition, but will now be placed on Bayer’s self-regulating treatment, that will free up much-needed public health resources and reduce the risk of exposure to the coronavirus in a crowded hospital environment,” explains Frans Labuschagne, country divisional head for Bayer’s Pharmaceutical Division in Southern Africa.
